Stomach News and Research

RSS

JRC's new report identifies lung cancer trends in Europe

Scientists at the Joint Research Centre, the European Commission's Science and Knowledge service, place Europe's regions under the microscope in a report identifying cancer trends within and across countries.

2 Aug 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Study shows spillover effect of evidence-based opioid prescribing for major procedures

To curb the use of opioids after major elective operations and prevent these pain relievers from falling into the wrong hands, surgeons at the University of Michigan developed prescribing recommendations based on published medical evidence for one operation, gall bladder removal, and then discovered a spillover effect that led them to prescribe roughly 10,000 fewer pills for other major operations, according to study results appearing as an "article in press" on the website of the Journal of the American College of Surgeons ahead of print.

27 Jul 2018

Cancer and heart disease are deadlier in the developing world than in western nations

Diseases such as cancer, heart disease and stroke are deadlier in the developing world than in rich nations. This is the finding of a new analysis from researchers at Imperial College London.

26 Jul 2018

Expert explains whether sparkling water is the same as plain water

The fruity, unique flavors and bright packaging of many seltzer and sparkling water brands have taken supermarkets by storm - and many people say these bubbly beverages get them to drink more water every day.

25 Jul 2018

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.

23 Jul 2018

PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides

PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech's milk-derived exosome platform technology for the oral administration of Roche's antisense oligonucleotide platform.

20 Jul 2018

Animal studies reveal brain changes responsible for appetite effects of cannabis

New research on how cannabis use alters eating behavior could lead to treatments for appetite loss in chronic illness, according to experts at Washington State University.

17 Jul 2018

Hunger hormones could be key to new treatments for drug, alcohol addiction

Hormones that signal the body's state of hunger and fullness could be the key to new treatments for drug and alcohol addiction.

17 Jul 2018

Captozyme begins cross-over study of Nephure oxalate reducing enzyme

Captozyme, Inc. announced today that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet.

12 Jul 2018

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma Corp. and Servier today announced that the pivotal Phase III study evaluating PIXUVRI® combined with rituximab in comparison to gemcitabine combined with rituximab in patients with aggressive B-cell non-Hodgkin lymphoma did not meet its primary endpoint of improvement of progression-free survival

9 Jul 2018

Step towards an HIV/AIDS vaccine

There has been a four decades long challenge to develop a vaccine against the deadly HIV virus that causes AIDS. Last Saturday the research bore fruit when a team of scientists announced that a trial drug has shown immune response in humans and also protected laboratory monkeys from HIV infection.

9 Jul 2018

Unique FoodSwitch app suggests healthier alternatives

Drop that yogurt. Instead, try this one with less sugar, fat and fewer unpronounceable additives. That's the message from FoodSwitch - a free mobile app developed by researchers from The George Institute and Northwestern University. Using FoodSwitch is like having a nutritionist at your side in the grocery store.

6 Jul 2018

Researchers develop ingestible sensor to non-invasively monitor indicators of disease

NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.

6 Jul 2018

Researchers find new marker for better prognosis in gastric and esophageal cancer

Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.

2 Jul 2018

Researchers focus on delivery of insulin in pill form

One mother vividly remembers her three-and-a-half-year-old son's pleas when he received insulin injections several times each day. "He would beg and plead, 'Don't do it Momma!'" she recalls.

29 Jun 2018

Psychologist suggests few guidelines on how to help children handle scary news

When tragic or violent events occur, parents may wonder about how to help their kids understand the graphic images and emotional video footage that they may see. Stephanie Marcy, PhD, psychologist at Children's Hospital Los angeles suggests a few guidelines to keep in mind so parents can be better equipped to help their children handle scary news.

28 Jun 2018